CAPE TOWN - The Johnson & Johnson vaccine rollout programme will resume through the Sisonke programme this week.
The Health Department has confirmed that it had all the doses it needed to complete vaccination of half a million healthcare workers through the early access protocol.
When the Sisonke programme resumes on Wednesday, vaccinations will be expanded to 95 sites across the country.
Government has confirmed that phase one of the vaccine rollout is expected to end on 16 May.
The Health Department remains committed to vaccinating as many of the country's 1.2 million healthcare workers despite the unforeseen stoppage of the Johnson & Johnson jab this month.
The programme was halted after half a dozen patients developed a blood clot after being vaccinated in the United States.
It has since been established that there's a one in a million chance of developing a clot after taking the vaccine. It also appears that women between the ages of 18 and 48 are particularly at risk.
With such a low probability of developing a clot, regulators across the world have recommended the continued use of the Johnson & Johnson treatment.
Health Minister Zweli Mkhize said now that the Johnson & Johnson vaccine rollout program can resume on Wednesday it’s an important development for the country especially with the third wave of COVID-19 infections on its way.
Mkhize said they had enough vaccines to ensure there is no further delay: “We are expecting 1,1 million vaccines from Aspen and Johnson & Johnson anytime now so that we know we can proceed with those. There is still another 2 million which should come between now and the end of June, which means that we can vaccinate another 3 million people with the Johnson & Johnson.”
Download the Eyewitness News app to your iOS or Android device.
This article first appeared on EWN : J&J vaccine rollout to resume on Wednesday, Health Dept confirms